Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Dose-Randomized, Vehicle-Controlled Study of PH-10-Aqueous Hydrogel for the Treatment of Plaque Psoriasis

NCT01247818 is registered in ClinicalTrials.gov with Provectus Pharmaceuticals as lead sponsor.

NCT NCT01247818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01247818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Dose-Randomized, Vehicle-Controlled Study of PH-10-Aqueous Hydrogel for the Treatment of Plaque Psoriasis
Lead sponsor
Provectus Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2010
Completion date
March 31, 2012
Enrollment
99 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis